New Applications of NMR in Drug Discovery and Development

Regular price €198.39
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Leoncio Garrido
B01=Nicolau Beckmann
Category1=Non-Fiction
Category=PNFR
COP=United Kingdom
Delivery_Delivery within 10-20 working days
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
Language_English
New
PA=Available
Price_€100 and above
PS=Active
softlaunch

Product details

  • ISBN 9781849734448
  • Weight: 989g
  • Dimensions: 156 x 234mm
  • Publication Date: 24 Jul 2013
  • Publisher: Royal Society of Chemistry
  • Publication City/Country: GB
  • Product Form: Hardback
  • Language: English
Secure checkout Fast Shipping Easy returns

This book presents a review of recent developments in NMR applications in pharmaceutical research. Consideration is given to consolidated and emerging techniques and methods in NMR, many of which are not widely applied but are likely to provide new opportunities for drug design.

The first part of the book is dedicated to the description of NMR as a tool for the analysis of chemicals and interaction with targets. Particular emphasis is put on applications with unexploited potential for drug discovery and development. The next seven chapters describe NMR approaches to investigate in vivo models of interest in drug discovery and development, with the attention focused on anatomy, function, metabolism and molecular-cellular aspects. Finally, consideration is given to the application of in vivo NMR to the identification and characterization of biomarkers with the aim of monitoring the outcome of therapeutic intervention in selected human diseases, including the study of drug metabolism and toxicity.

Aimed at NMR spectroscopists and pharmaceutical scientists, this title will be invaluable at putting NMR within context in its role in drug discovery and development. This resource will be essential reading for those both new and already active in these areas.

AstraZeneca, UK